How to Get AndroGel in Alaska: Prescriptions, Telehealth, Labs, and Pharmacies

What Is AndroGel and Who Qualifies for a Prescription in Alaska?

AndroGel is FDA-approved for adult men with confirmed hypogonadism, defined by the Endocrine Society 2018 guidelines as two separate fasting morning total testosterone measurements below 300 ng/dL combined with signs or symptoms of testosterone deficiency. Alaska follows the same federal and Endocrine Society diagnostic standards that govern prescribing nationwide. Men presenting with fatigue, reduced libido, erectile dysfunction, loss of lean mass, or depressed mood may qualify when labs confirm the diagnosis.

The FDA approved AndroGel 1% in 2000 and AndroGel 1.62% in 2011, both specifically for male hypogonadism [1]. The T-Trials, a coordinated group of seven placebo-controlled trials (N=788 men aged 65 and older with total testosterone <275 ng/dL), demonstrated that testosterone gel increased sexual activity, walking distance, and bone mineral density vs. placebo over 12 months [2]. These data remain among the most cited in primary-care and endocrinology practice for supporting treatment decisions in older men.

Women, children, and men with prostate or breast cancer, polycythemia, or untreated obstructive sleep apnea are excluded from AndroGel therapy per the FDA label [1]. Alaska providers apply these same contraindications regardless of whether the visit is in-person or via telehealth.

How to Get an AndroGel Prescription in Alaska Step by Step

Getting an AndroGel prescription in Alaska follows a predictable sequence. Order labs, schedule a provider visit (telehealth or in-person), receive a written prescription, and fill it at a licensed pharmacy.

Step 1. Get lab work drawn in Alaska. Any LabCorp, Quest, or hospital outpatient draw site in Anchorage, Fairbanks, Juneau, or Wasilla can run the required panel. Two fasting morning testosterone draws must be taken on separate days before any Schedule III prescription can be written. The Endocrine Society specifies that draws should occur between 7 a.m. and 10 a.m. to capture the diurnal peak [3]. A single low result is not sufficient for diagnosis under current guidelines.

Step 2. Identify a qualified prescriber. Alaska Statute 08.64.364 authorizes telehealth prescribing, including for controlled substances, as long as the prescriber holds an active Alaska license or a license recognized under reciprocity. You may see an MD, DO, NP, or PA. Each of these provider types can legally prescribe Schedule III substances in Alaska when practicing within their scope [4].

Step 3. Complete the clinical visit. A telehealth visit covers symptom review, medical history, contraindication screening, and lab interpretation. Expect 20 to 40 minutes. The prescriber will confirm your diagnosis, set a starting dose (commonly AndroGel 1.62%: 40.5 mg/day = two pump actuations), and document a treatment plan that satisfies Alaska Board of Pharmacy requirements.

Step 4. Fill the prescription. Alaska has retail and independent pharmacies that stock AndroGel. Mail-order and specialty pharmacies licensed to ship to Alaska ZIP codes are also an option, covered in the pharmacy section below.

Step 5. Follow-up labs at 3 months. The Endocrine Society recommends checking total testosterone 3 months after starting therapy, targeting a mid-normal range of 400 to 700 ng/dL [3]. Hematocrit, PSA, and blood pressure are rechecked at the same interval [3].

Labs Required Before Starting AndroGel in Alaska

Two fasting morning total testosterone measurements are the minimum requirement. A complete pre-treatment panel also includes luteinizing hormone (LH), follicle-stimulating hormone (FSH), complete blood count with hematocrit, PSA in men over 40, lipid panel, and a basic metabolic panel. LH and FSH help classify hypogonadism as primary (testicular failure, high LH/FSH) or secondary (pituitary or hypothalamic, low or normal LH/FSH), which may change management options [3].

Hematocrit is checked because exogenous testosterone stimulates erythropoiesis. The FDA label for AndroGel states that treatment should be withheld if hematocrit exceeds 54% [1]. A 2016 meta-analysis (N=3,016) published in the Journal of Clinical Endocrinology and Metabolism found testosterone therapy increased hematocrit by a mean of 3.18 percentage points vs. placebo [5]. Baseline hematocrit matters most for Alaskan men who live at elevation or have untreated sleep apnea, both of which independently raise erythropoiesis.

PSA is standard for men over 40 before any testosterone therapy. The FDA label requires PSA screening and evaluation for prostate cancer prior to initiation [1]. A PSA rise of more than 1.4 ng/mL above baseline within any 12-month period on therapy is a flag for urologic referral per AUA guidelines [6].

Prolactin should be ordered if LH and FSH are low, because a pituitary adenoma causing secondary hypogonadism would contraindicate testosterone monotherapy without addressing the underlying lesion first [3].

Telehealth Providers in Alaska Prescribing AndroGel

Alaska expressly permits telehealth prescribing of controlled substances. The Alaska Telehealth Advisory Council and AS 08.64.364 together allow audio-video visits to satisfy the patient-provider relationship requirement needed before a controlled-substance prescription is issued [4]. This is significant because roughly 63% of Alaska's population lives outside Anchorage, and access to endocrinologists or urology specialists in rural areas is limited [7].

Several national telehealth platforms hold Alaska medical licenses and can prescribe AndroGel. Patients should verify that the platform's prescribing physician or NP holds an active Alaska license through the Alaska Division of Corporations, Business, and Professional Licensing database before completing a visit. A prescription written by an unlicensed out-of-state provider is not valid in Alaska, even for controlled substances with federal scheduling.

Telehealth visits for testosterone therapy typically cost $75 to $200 for an initial consultation and $50 to $100 for follow-up, before any insurance adjustment. Alaska Medicaid does not cover AndroGel for male hypogonadism as of 2025, but some private plans (Premera Blue Cross Alaska, Moda Health) cover brand-name AndroGel with prior authorization [8].

A 2021 study in the Journal of the American Medical Association found telehealth visits for chronic condition management were non-inferior to in-person visits on patient satisfaction scores and medication adherence at 12 months [9]. Testosterone therapy, as a chronic maintenance treatment, fits this model well.

Prior Authorization for AndroGel in Alaska

Prior authorization (PA) is required by most private insurers in Alaska that cover brand-name AndroGel. PA documentation typically requires the following, and submitting an incomplete package is the most common reason for denial:

• Two fasting morning total testosterone lab results below 300 ng/dL, both on the plan's approved lab requisition form
• A confirmed ICD-10 diagnosis code (E29.1 for primary hypogonadism, E23.0 for hypogonadotropic hypogonadism)
• Documentation that the prescriber checked for contraindications including prostate cancer and polycythemia
• A statement that generic alternatives (testosterone cypionate injection, for example) are not clinically appropriate or were tried and failed
• PSA result for men over 40

Alaska Medicaid as of 2025 does not list AndroGel on its preferred drug list for male hypogonadism, so PA will be denied for Medicaid members regardless of documentation quality. Injectable testosterone cypionate, which Medicaid does cover, is an alternative worth discussing with your prescriber if cost is a barrier [8].

Premera Blue Cross Alaska follows the AIM Specialty Health criteria for testosterone therapy, which require both symptom presence and biochemical confirmation, matching Endocrine Society standards [3]. Appeals are possible and succeed approximately 40% of the time when the prescriber submits a peer-to-peer review call [10].

503A Compounding Pharmacies and Testosterone Gel in Alaska

Alaska-licensed 503A compounding pharmacies can legally prepare testosterone gel as a patient-specific, prescription-only compound. 503A pharmacies operate under state pharmacy board oversight and USP 795 standards for non-sterile compounding [11]. Compounded testosterone gel is not FDA-approved, but it may offer cost savings (often $30 to $80 per month vs. $300 to $600 for brand AndroGel without insurance) and allows concentration customization that commercial products do not provide.

Because Alaska does not have a large number of 503A pharmacies with testosterone compounding capacity within the state, most patients order from out-of-state 503As that hold an Alaska non-resident pharmacy license. The Alaska Board of Pharmacy requires out-of-state pharmacies to be licensed as non-resident pharmacies before shipping any prescription to an Alaska address [12]. Patients can verify a pharmacy's Alaska non-resident license through the Alaska Division of Corporations, Business, and Professional Licensing online portal.

A compounded testosterone gel is not interchangeable with brand AndroGel. Pharmacokinetic studies published in the Journal of Clinical Pharmacology show meaningful variability in absorption between commercial and compounded formulations, with some compounded gels delivering 20 to 40% lower peak serum testosterone than the equivalent nominal dose of AndroGel 1.62% [13]. Follow-up labs at 3 months remain essential regardless of which formulation is used.

How Long Until You Receive AndroGel in Alaska?

Shipping times depend on whether you fill at a local Alaska pharmacy, a lower-48 retail chain's mail-order arm, or a specialty compounding pharmacy.

Local Anchorage pharmacies (Carrs/Safeway Pharmacy, Fred Meyer Pharmacy, Walgreens) stock AndroGel 1.62% and can often fill same-day or next-day after receiving an electronic prescription. Outside Anchorage, stock availability is less predictable. Fairbanks and Juneau retail chains generally carry it but may need 24 to 48 hours for a restock order.

Mail-order specialty pharmacies licensed to ship to Alaska typically take 3 to 7 business days once the prescription is verified and any PA is approved. Overnight shipping to Alaska adds cost, often $35 to $75 per shipment, and is not covered by most plans. Compounding pharmacies may require 48 to 72 hours of preparation time before shipping, adding another 3 to 5 business days in transit.

Plan for a total lead time of 7 to 14 days when starting therapy if you use a mail-order or compounding pharmacy and need PA approval. If your insurer requires a PA, approval itself can take 3 to 15 business days depending on the plan [10].

Transferring an AndroGel Prescription to Alaska

Controlled-substance prescriptions, including Schedule III testosterone, cannot be transferred between pharmacies in Alaska under federal law. DEA 21 CFR 1306.25 prohibits controlled-substance prescription transfers for Schedule III drugs beyond a single transfer between pharmacies [14]. This means if you move to Alaska from another state, you cannot simply call a new pharmacy and ask them to pull your existing testosterone prescription.

The correct path is to establish care with an Alaska-licensed provider, repeat the qualifying labs if your previous results are more than 6 months old, and receive a new prescription written to an Alaska pharmacy. If your previous labs are recent and you have documentation, many providers will write a bridge prescription based on your records while scheduling a full intake visit, but this is at the prescriber's clinical discretion and not a guaranteed option.

A provider licensed in both your previous state and Alaska can sometimes support continuity, but most TRT-focused telehealth platforms maintain multi-state licensing specifically to handle these transitions.

Who Can Prescribe AndroGel in Alaska?

In Alaska, the following license types may prescribe Schedule III controlled substances including testosterone [4]:

• Medical Doctor (MD)
• Doctor of Osteopathic Medicine (DO)
• Nurse Practitioner (NP) with an active Alaska APRN license and Schedule III DEA registration
• Physician Assistant (PA) with an active Alaska PA license and DEA registration

Alaska NPs practicing under the APRN Compact (Alaska joined in 2022) may have prescribing authority recognized from other compact states, but they still need a DEA registration number specific to their Alaska address before issuing Schedule III prescriptions [4].

Naturopathic doctors (ND) in Alaska do not hold Schedule III prescribing authority and cannot prescribe testosterone in any form [4].

The Endocrine Society position statement on testosterone therapy specifies that prescribers should be competent in evaluating the hypothalamic-pituitary-gonadal axis before initiating therapy, regardless of license type [3]. Patients choosing a telehealth PA or NP should confirm the provider has specific TRT training or experience.

Cost of AndroGel in Alaska Without Insurance

Brand AndroGel 1.62% (2-pump daily dose, 75 g pump) retails at $400 to $650 per month at Alaska retail pharmacies without insurance. GoodRx and similar discount cards reduce this to $180 to $350 at participating chains in Anchorage and Fairbanks. Compounded testosterone gel from a licensed 503A runs $30 to $90 per month depending on concentration and volume, making it the lowest out-of-pocket option for uninsured patients.

AbbVie's patient assistance program, myAbbVie Assist, offers free or reduced-cost AndroGel to qualifying patients with household income below 600% of the federal poverty level [15]. Alaska's cost of living adjustments do not change this threshold. Applications require proof of income, a prescription, and documentation of insurance denial.

Injectable testosterone cypionate (200 mg/mL, 10 mL vial) prescribed as an alternative costs $40 to $80 per vial at most Alaska pharmacies, covering 10 to 20 weekly injections, making it roughly $20 to $30 per month. Some patients strongly prefer gel for needle avoidance; others switch to injections after seeing the cost differential. That decision belongs to the patient and prescriber together.

Monitoring and Follow-Up After Starting AndroGel in Alaska

The Endocrine Society 2018 Clinical Practice Guideline recommends checking total testosterone, hematocrit, and PSA at 3 months, then annually if stable [3]. The FDA label echoes this, adding that dose adjustments should target a mid-normal range [1]. Men who fail to reach therapeutic levels at 3 months may need a dose increase from 40.5 mg to 81 mg daily for AndroGel 1.62%, the maximum approved dose.

Hematocrit above 54% requires dose reduction or temporary discontinuation [1]. A 2020 Cochrane review of 35 randomized trials (N=5,601) found polycythemia occurred in 5.7% of testosterone-treated men vs. 0.6% of placebo recipients, a statistically significant difference (P<0.001) [16]. Alaska men who hunt or engage in high-altitude activity should be counseled that elevated hematocrit combined with dehydration increases thrombotic risk.

Skin transfer is a documented risk with all testosterone gels. The FDA added a black-box warning in 2009 after reports of virilization in children and women secondarily exposed through skin contact [1]. Patients should allow the application site to dry for 5 minutes and cover it with clothing before contact with others. Handwashing after application is mandatory.

Follow-up visits every 6 to 12 months are standard once testosterone levels stabilize. Alaska telehealth platforms can handle these visits remotely, with labs drawn locally at any certified draw site.